AI in Clinical Trials Faces New Regulatory Scrutiny Over Data Rights
New regulatory challenges emerge as AI becomes central to U.S. clinical trials, with focus on data rights agreements and FDA compliance under FDA guidelines. #AI #HealthcareRegulation